Research background · Updated November 1, 2026
HGH Fragment 176-191 Research: Publications, Study Types and Background
Short answer
HGH Fragment 176-191. As of November 1, 2026, PubMed indexes 9 records matching HGH Fragment 176-191, the earliest from 1978; 1 were published in 2021–2025 and 0 are reviews. ClinicalTrials.gov lists 0 registered studies matching the compound.
- PubMed records
- 9
- Earliest record
- 1978
- Published 2021–2025
- 1
- Reviews
- 0
- Animal-only studies
- 6
- Registered studies
- 0
Publications per year, 2006–2025
1 records in 2016–2025 against 0 in 2006–2015; the busiest year was 2022, with 1.
See the numbers
| Year | PubMed records |
|---|---|
| 2006 | 0 |
| 2007 | 0 |
| 2008 | 0 |
| 2009 | 0 |
| 2010 | 0 |
| 2011 | 0 |
| 2012 | 0 |
| 2013 | 0 |
| 2014 | 0 |
| 2015 | 0 |
| 2016 | 0 |
| 2017 | 0 |
| 2018 | 0 |
| 2019 | 0 |
| 2020 | 0 |
| 2021 | 0 |
| 2022 | 1 |
| 2023 | 0 |
| 2024 | 0 |
| 2025 | 0 |
Study types
| All PubMed records | 9 |
|---|---|
| Reviews | 00% |
| Animal studies (no human subjects indexed) | 667% |
| Indexed as clinical trials | 00% |
| Registered on ClinicalTrials.gov | 0 |
Categories overlap and follow PubMed’s own indexing; recent records may not be indexed yet.
Primary research directions
What 1 of the most-cited and most recent HGH Fragment 176-191 papers report, in their own authors’ terms. Each line links the paper it came from.
Insulin release from islets
Synthetic fragments from the C-terminal end of growth hormone, including hGH 172-191, potentiated glucose-stimulated insulin release from isolated islets, by a mechanism the authors conclude is independent of islet cAMP changes.
CellsWeerasinghe C 1978The American journal of physiologyPMID 206156
Most-studied topics
The Medical Subject Headings (MeSH) PubMed indexers most often marked as a main topic, across 9 of the 9 records. They describe what the literature is about, not what HGH Fragment 176-191 does.
- Growth Hormone8 papers
- Adipose Tissue3 papers
- Lipids2 papers
- Antineoplastic Agents1 papers
- Breast Neoplasms1 papers
- Chitosan1 papers
- Human Growth Hormone1 papers
- Nanoparticles1 papers
Key papers
Earliest indexed record
Weerasinghe C (1978). The American journal of physiology.
PMID 206156Most-cited paper · 18 citations
Newman JD (1978). Biochimica et biophysica acta.
PMID 214153Most-cited #2 · 9 citations
Wu Z (1993). Biochemistry and molecular biology international.
PMID 8358331Most-cited #3 · 8 citations
Habibullah MM (2022). Drug design, development and therapy.
PMID 35783198
Citation counts from NIH iCite, among the 9 records sampled. Titles are left out; open each record on PubMed to read it.
Identity
| Molecular formula | C80H127N23O24S2 |
|---|---|
| Molecular weight | 1859.1 g/mol |
| Synonyms | HGH Fragment 176-191, GLXC-21568 |
Identity data from PubChem, retrieved November 1, 2026, on the HGH Fragment 176-191 page.
How these numbers were counted
- PubMed search, run November 1, 2026:
"hGH fragment 176-191"[tiab] OR "GH 176-191"[tiab] OR "GH(177-191)"[tiab] OR "hGH 177-191"[tiab]re-run it. Study types add PubMed’s own filters (review, clinical trial, animals not humans). - Topics: MeSH major-topic headings counted across up to 400 of the matching records; headings for study set-up (species, sex, age) are left out.
- Citations: NIH iCite citation counts for the same records.
- ClinicalTrials.gov search:
"hGH fragment 176-191"re-run it. Any phase, any status.
This page reports what has been published and what papers say they found, with each source linked. It gives no dosing or usage information, and nothing here is a reason to use HGH Fragment 176-191 outside a laboratory.
Wholesale supply
HGH Fragment 176-191, sourced to order for research.
Not held in the listed catalog. Tell us the vial size and the number of vials and we come back with availability, documentation and pricing in writing.
HGH Fragment 176-191 research questions
How much research has been published on HGH Fragment 176-191?
PubMed indexes 9 records matching HGH Fragment 176-191 (searched November 1, 2026), including 0 reviews and 0 records indexed as clinical trials. 1 were published in the five years 2021–2025.
When was HGH Fragment 176-191 first described in the literature?
The earliest PubMed record matching HGH Fragment 176-191 is from 1978 (Weerasinghe C, The American journal of physiology, PMID 206156).
What topics does the HGH Fragment 176-191 literature cover?
The subject headings PubMed indexers most often marked as a main topic of HGH Fragment 176-191 papers are Growth Hormone, Adipose Tissue, Lipids, Antineoplastic Agents. These describe what the literature is about. Findings from individual papers, with their sources, are summarized on this page.
Is HGH Fragment 176-191 sold for human use?
No. Vanta Foundry supplies it for laboratory research use only. Not for human or veterinary use, and not a drug, food, cosmetic or dietary supplement.
Where can I buy HGH Fragment 176-191 wholesale for research?
We source HGH Fragment 176-191 to order rather than stock it. Tell us the vial size and number of vials on WhatsApp or by email and the quote confirms availability, documentation and pricing.
Research materials supplied by Vanta Foundry are for laboratory research use only. They are not for human or veterinary use and are not drugs, foods, cosmetics or dietary supplements. Websites and payment processing are business services for research-supply brands.
All compounds: research peptide publication statistics.